Marker Therapeutics
MRKR
MRKR
43 hedge funds and large institutions have $86.4M invested in Marker Therapeutics in 2018 Q4 according to their latest regulatory filings, with 21 funds opening new positions, 11 increasing their positions, 4 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
43
Holders Change
+12
Holders Change %
+38.71%
% of All Funds
0.96%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
21
Increased
11
Reduced
4
Closed
8
Calls
$190K
Puts
$12K
Net Calls
+$178K
Net Calls Change
-$171K
Top Buyers
| 1 |
NMC
NEA Management Company
Timonium,
Maryland
|
+$27.8M |
| 2 |
PA
Perceptive Advisors
New York
|
+$11.1M |
| 3 |
BBA
Baker Bros. Advisors
New York
|
+$8.33M |
| 4 |
AC
Armistice Capital
New York
|
+$8.26M |
| 5 |
6CM
683 Capital Management
New York
|
+$7.55M |
Top Sellers
| 1 |
CH
CVI Holdings
Wilmington,
Delaware
|
-$2.26M |
| 2 |
RI
RTW Investments
New York
|
-$1.9M |
| 3 |
MA
MYDA Advisors
Woodmere,
New York
|
-$424K |
| 4 |
Millennium Management
New York
|
-$315K |
| 5 |
CC
Caxton Corporation
Princeton,
New Jersey
|
-$157K |
